Lung bath chemo during surgery aims to wipe out hidden sarcoma cells
NCT ID NCT02811523
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a technique called in vivo lung perfusion (IVLP) that delivers chemotherapy directly into the lung during surgery to remove sarcoma tumors that have spread to the lungs. The goal is to kill any tiny cancer cells left behind that could cause the cancer to come back, while reducing side effects on the rest of the body. About 17 people with sarcoma in both lungs will take part. One lung will get the IVLP treatment and the other will receive standard care, so doctors can compare safety and effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a targeted pill stall advanced sarcomas?
- Smartwatch exercise plan aims to rebuild fitness in young cancer survivors
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells